Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders.

Education

Pharmaceutical

Xenon Pharmaceuticals

Xenon Pharmaceuticals' headquarters in Burnaby, Canada

Ian Mortimer

Ryan Bovia

Christopher Kenney

Matthew Ronsheim

Tucker Kelly

Darren Cline

Colleen Minden Alabiso

Todd Kenney

Andrea Difabio

Joe McIntosh

Shelley McCloskey

James Empfield

Robin Sherrington

This department oversees the development, manufacturing, and regulatory compliance of chemical and biological products.

CMC and Regulatory Affairs

The Research and Development team at Xenon Pharmaceuticals spearheads the creation and advancement of groundbreaking neurological disorder treatments. This team, comprised of leaders in drug discovery, R&D operations, and chemistry, as well as research interns, drives the strategic planning, laboratory research, and clinical trial oversight necessary to bring new, life-changing medications to market.

Research and Development

This department ensures compliance with quality standards and regulations in all relevant processes and products.

Quality Assurance

This department conducts studies and analyses to advance knowledge and develop innovative solutions.

Research Department

This department manages employee relations, recruitment, compliance, and organizational development to support the workforce.

Human Resources

This department manages and oversees clinical trial processes and operations for research studies.

Xenon Pharmaceuticals

Org chart

Teams

CMC and Regulatory Affairs

Research and Development

Quality Assurance

Research Department

Human Resources

Clinical Trials

Offices

Xenon Pharmaceuticals

Org chart

Teams

CMC and Regulatory Affairs

Research and Development

Quality Assurance

Research Department

Human Resources

Clinical Trials

Offices

Related companies